Find information on thousands of medical conditions and prescription drugs.

Sulfasalazine

Sulfasalazine is a sulfa drug used primarily in the treatment of inflammatory bowel disease. It is a 5-aminosalicylic acid derivative. It is sold as Azulfidine in the United States. It is also used for rheumatoid arthritis (see Disease-modifying antirheumatic drugs). It is usually not given to children under 2 years of age. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
Growth hormone
Salbutamol
Salmeterol
Sandimmune
Sandostatin
Sansert
Saquinavir
Sarafem
Satric
Scopolamine
Seasonale
Secobarbital
Secretin
Selegiline
Semprex-D
Sensipar
Sensorcaine
Serax
Serevent
Serine
Seroquel
Serostim
Serrapeptase
Sertindole
Sertraline
Serzone
Sevelamer
Sevoflurane
Sibutramine
Sildenafil
Silibinin
Simvastatin
Sinemet
Sinequan
Singulair
Sirolimus
Skelaxin
Sodium cyclamate
Solage
Soma
Somatostatin
Sotahexal
Sotalol
Sotret
Spiperone
Spiriva
Spironolactone
Sporahexal
Sporanox
SPS
SSD
Stanozolol
Stavudine
Stelazine
Stilbestrol
Stilbetin
Stimate
Stiripentol
Strattera
Streptokinase
Streptomycin
Suboxone
Subutex
Sucralfate
Sucralfate
Sufentanil
Sulbactam
Sulfamethoxazole
Sulfanilamide
Sulfasalazine
Sulforidazine
Sulla
Sulpiride
Sultamicillin
Sumatriptan
Suprefact
Suramin sodium
Sustaire
Sustiva
Suxamethonium chloride
Symmetrel
Synarel
Synercid
Synthroid
Syntocinon
Zaleplon
T
U
V
W
X
Y
Z

Side effects

  1. diarrhea
  2. headache

Brand Names

  • Azulfidine ®
  • Salazopyrin ®
  • Pyralin ®

MIMS Guide to Sulfasalazine

Section: 1(d) Antidiarrhoeals Pregnancy Category: A

Sport Category: Permitted in sport

Uses/Indications: Ulcerative colitis; Inflammatory Bowel Syndrome; Crohn's disease; rheumatoid arthritis unresponsive to NSAIDs

Contraindications: Haematological, renal or hepatic dysfunction; hypersensitivity to salicylates or sulfonamide derivatives; GI or urinary tract obstruction; porphyria; children < 2 yrs

Precautions: Perform blood counts, urinalysis before and during treatment; maintain fluid intake; G-6-PD deficiency; atopy; slow acetylators; lactation

Adverse Reactions: Hypersensitivity; GI upset; fever; rash; headache; oligospermia; folate deficiency; others, see full PI

Drug Interactions: Oral anticoagulants; methotrexate; sulfonylurea hypoglycaemics; urinary acidifiers; phenylbutazone; indomethacin; sulfinpyrazone; salicylates; antacids, ferrous sulfate (concurrent); penicillins, oxacillin; some local anaesthetics; digoxin

PYRALIN EN (Tablets) Prescription required. S4 Sulfasalazine; yellow e-c tab; Dose: Should be taken with food. GI disease. Initial dosage. Adults: 1-2 g 4 times daily; children: 40-60 mg/kg daily in 3-6 divided doses. Maintenance. Adults: 2 g daily in 4 divided doses; children: 40 mg/kg daily in 4 divided doses. Rheumatoid arthritis. Adults: 1 g 2-3 times daily Pack: 500 mg x2 Brand substitution is permitted. : PBS/RPBS (Rp 5) PBS: $58.15

Actions

Pharmacodynamics.

Sulfasalazine has, among others, an immunosuppressive effect and has shown affinity to connective tissue. It has also been shown to have a wide range of effects in other biological systems. It is, however, difficult to judge the clinical relevance of its various pharmacological actions since the aetiology of rheumatoid arthritis is largely unknown. Moreover, the mode of action of sulfasalazine in the treatment of ulcerative colitis is also not known. A metabolite of the drug may have an inhibitory effect on an antigen-antibody process occurring in the intestinal wall and the salicylate component may act as an anti-inflammatory agent. The drug does not appear to have any long-term antibacterial effect on the stool flora of patients with ulcerative colitis (see Antibacterial effect, below).

The following effects have been found in vitro: inhibition of bacterial growth; inhibition of prostaglandin synthesis; increased intestinal cytoprotection due to inhibition of prostaglandin degradation; reduction of leukotriene formation; modulation of polymorphonuclear leucocyte function; inhibition of proteolytic enzymes; inhibition of DNA synthesis; and impairment of folate absorption and metabolism.

Read more at Wikipedia.org


[List your site here Free!]


Sulfasalazine 250-mg/5-mL oral liquid
From International Journal of Pharmaceutical Compounding, 11/1/03

METHOD OF PREPARATION

Note: It is best to use the sulfasalazine powder when preparing this oral liquid. As an alternative, sulfasalazine immediate-release tablets can be used.

1. Calculate the required quantity of each ingredient for the total amount to be prepared.

2. Accurately weigh and/or measure each ingredient.

3. Mix the sulfasalazine with the glycerin to form a smooth paste.

4. Geometrically, incorporate the Ora-Plus and mix thoroughly.

5. Add sufficient Ora-Sweet or Ora-Sweet SF to volume and mix well.

6. Package and label.

PACKAGING

Package in tight, light-resistant containers.1

LABELING

Shake well before taking. Keep out of reach of children. Use only as directed.

STABILITY

A beyond-use date of 30 days would be appropriate for this preparation.1

USE

Sulfasalazine oral liquid is used in the treatment of inflammatory bowel disease and rheumatoid arthritis.2

QUALITY CONTROL

Quality-control assessment can include weight/volume, pH, specific gravity, active-drug assay, color, rheological properties/pourability, physical observation and physical stability (discoloration, foreign materials, gas formation, mold growth).3

DISCUSSION

Sulfasalazine 250 mg/5 mL was formerly manufactured by Pharmacia-Upjohn under the brand name of Azulfidine. The formulation presented here can be easily modified if a more or less concentrated preparation is required. Since this formulation is not the same as the commercial preparation, a conservative beyond-use date of 30 days is recommended.

Sulfasalazine (C^sub 18^H^sub 14^N^sub 4^O^sub 5^S, MW 398.39) occurs as a bright yellow or brownish-yellow, odorless, fine powder that melts at about 255°C with decomposition. It is very slightly soluble in alcohol (1 g in 2900 mL) and practically insoluble in water. It is soluble in aqueous solutions of alkali hydroxides. It should be protected from light.1

Glycerin (C^sub 3^H^sub 8^O^sub 3^, MW 92.10, glycerol, 1,2,3-propane triol) occurs as a clear, colorless, odorless, viscous, hygroscopic liquid with a sweet taste about two thirds as sweet as that of sucrose. It has a specific gravity of about 1.25 and a melting point of 17.8°C; if cooled to crystallization, it will need to be heated to about 20°C to melt. It is miscible with water, methanol and 95% ethanol; practically insoluble in oils and chloroform and slightly soluble in acetone. It is hygroscopic and should be stored in airtight containers in a cool place. It is not prone to oxidation but will decompose on heating. When mixed with water, ethanol and propylene glycol, the mixtures are chemically stable.4

Ora-Plus is an oral suspending vehicle that accepts dilution of up to 50% or more with water, flavoring agents or syrups and still retains its suspending properties. It has a pH of approximately 4.2 and an osmolality of about 230 mOsm/Kg. It is a thixotropic vehicle with a viscosity of approximately 1000 cps at 25°C. It contains purified water, microcrystalline cellulose, sodium carboxymethylcellulose, xanthan gum, carrageenan, sodium phosphate and citric acid as buffering agents, simethicone as an antifoaming agent, and potassium sorbate and methylparaben as preservatives.5

Ora-Sweet syrup vehicle is a flavoring vehicle for oral extemporaneous preparations. It is flavored with a citrus-berry flavor blend and contains glycerin and sorbitol to prevent "cap-lock," a problem associated with many syrups. It is buffered to a pH of approximately 4.2 and has an osmolality of about 3240 mOsm/Kg. It contains purified water, sucrose, glycerin, sorbitol (5%), flavoring, sodium phosphate and citric acid as buffering agents, and potassium sorbate and methylparaben as preservatives.5

Ora-Sweet SF is a flavoring vehicle for oral extemporaneous preparations. It is a sugar-free, alcohol-free syrup flavored with a citrus-berry flavor blend. It is buffered to a pH of approximately 4.2 and may be used alone or in combination with other vehicles. It will tolerate a dilution to 50% with dissolved actives in water or suspending agents and still retain an acceptable taste. It has an osmolality of 2150 mOsm/Kg. It contains water, sodium saccharin, xanthan gum, glycerin, sorbitol, citric acid and sodium citrate as buffers; methylparaben, propylparaben and potassium sorbate as preservatives; and flavoring agents.5

REFERENCES

1. US Pharmacopeial Convention, Inc. United States Pharmacopeia 26-National Formulary 21. Rockville, MD:US Pharmacopeial Convention, Inc.; 2003:2197-2201, 2583.

2. Sweetman Sean C. MARTINDALE: The Extra Pharmacopeia. 33rd ed. London:Pharmaceutical Press; 2002:1251-1253.

3. Allen LV Jr. Standard operating procedure for performing physical quality assessment of oral and topical liquids. IJPC 1999;3:146-147.

4. Price JC. Glycerin. In: Kibbe AH, ed. Handbook of Pharmaceutical Excipients. 3rd ed. Washington, DC:American Pharmaceutical Association; 2000:220-222.

5. Ora-Plus/Ora-Sweet/Ora-Sweet SF [product information]. Minneapolis, MN:Paddock Laboratories, Inc.

Copyright International Journal of Pharmaceutical Compounding Nov/Dec 2003
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Sulfasalazine
Home Contact Resources Exchange Links ebay